Dr Bernard Fritzell, MD

Dr Bernard Fritzell is an independent consultant with 35 years’ experience in the clinical development of vaccines

• Major Contributions to the understanding of polysaccharide conjugate vaccines including Haemophilus influenza type B, meningococcal group A & C and Streptococcus pneumoniae and associated vaccination strategies
• Contributions to the clinical development of Hepatitis B, rabies and live attenuated Influenza vaccines,
• Established relationship between antibiotic resistance and SP serotypes

Prior experience:
• President of BFL councils, Bordeaux France (2012-present)
• Vice president international scientific and clinical affairs, Wyeth/Pfizer Vaccines, Paris, France (1999-2012)
• Former Chairman of the clinical working group of the European Vaccines Manufacturers (EVM) (1996-2010)
• Vice President, Clinical Research and Medical Affairs, Chiron Vaccines, Siena, Italy (1996-1999)
• Head of clinical research in the medical department of Pasteur-Merieux-Connaught, Paris, France (1993-1996)
• Director Clinical Research, Connaught Laboratories Inc., Swiftwater PA, USA (1991-1993)
• Director Clinical Research, Pasteur-Mérieux Sérums et Vaccins, Marne-la-Coquette, France (1989-1991)
• International Medical Director, Institut Pasteur Production/Pasteur Vaccins, Marne-la-Coquette France (1983- 1989),
• Governmental position at the ministry of health in Somalia (1981-1983)
• Medical Attaché to the French Embassy in Beijing, China (1978-1979)

• Degree in Statistics applied to Epidemiology and Clinical Research, University Pierre et Marie Curie, Paris VI, France
• Degree in Health and development, University of Bordeaux, France
• Degree in Tropical diseases, University of Bordeaux, France
• Medical Degree, University of Bordeaux, France